(Reuters) - Eli Lilly and Co said its diabetes drug was more effective than Sanofi SA's approved drug, Lantus, in reducing blood sugar levels in late-stage trials. The drug, basal insulin peglispro, showed improved blood sugar levels, compared with Lantus in patients with type 1 diabetes as well as type 2. Lilly said it was on track to file a submission with the U.S. Lilly's drug is being studied as a once-daily treatment for both type 1 and type 2 diabetes. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment